# OnCo record ph-like-all (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/ph-like-all/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "ph-like-all" ;
  schema:name "Ph-like (BCR::ABL1-like) acute lymphoblastic leukaemia"@en ;
  schema:alternateName "Ph-like"@en, "Ph-like ALL"@en, "BCR::ABL1-like ALL"@en, "BCR-ABL1-like"@en, "Philadelphia chromosome-like ALL"@en, "Ph-like signature"@en, "Ph-like gene expression signature"@en, "CRLF2 rearrangement"@en, "CRLF2-rearranged"@en, "CRLF2 overexpression"@en, "ABL-class fusion"@en, "ABL-class fusions"@en, "JAK-STAT class ALL"@en, "EPOR rearrangement"@en ;
  schema:description "Ph-like leukaemia has the gene-expression fingerprint of Philadelphia-positive leukaemia without the Philadelphia chromosome; behind it are dozens of kinase fusions and JAK pathway lesions, and finding which one is present tells doctors whether an imatinib-type drug or a JAK inhibitor might be added to chemotherapy."@en ;
  schema:url <https://onco.cc/terms/ph-like-all/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:related <https://onco.cc/terms/philadelphia-chromosome/>, <https://onco.cc/terms/b-all-cytogenetic-risk/>, <https://onco.cc/drugs/dasatinib/>, <https://onco.cc/drugs/imatinib/>, <https://onco.cc/drugs/ruxolitinib/>, <https://onco.cc/technologies/rna-seq/>, <https://onco.cc/terms/fish/>, <https://onco.cc/terms/flow-cytometry/>, <https://onco.cc/terms/mrd/>, <https://onco.cc/drugs/blinatumomab/> ;
  onco:cancers <https://onco.cc/cancers/all-ph-like/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/all-paediatric-high-risk/> .